TORONTO, March 11, 2021 (GLOBE NEWSWIRE) — via InvestorWire- Avicanna (AVCNF) today announced that Aras Azadian, CEO, will be attending the Q1 Virtual Investor Summit.
| Event | Q1 Investor Summit | ||
| Date | March 23-25th, 2021 | ||
| Presentation | March 24th @ 2:00PM ET | ||
| Location | https://zoom.us/webinar/register/WN_gqM8YnegRIqpec0qI9JuVw |
About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website at www.investorsummitgroup.com
Contact:
Brittney Blocker at brittney@investorsummitgroup.com
ABOUT Avicanna
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Wire Service Contact:
InvestorWire (IW)
Los Angeles, California
212.418.1217 Office
Editor@InvestorWire.com
Profession Ranks #1 for Best Job, Best Health Care Job and Best STEM Job AUSTIN,…
LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- Informa Connect announces a landmark collaboration with Behavioral…
DELRAY BEACH, Fla., Jan. 15, 2025 /PRNewswire/ -- The global AI medical imaging market, valued at…
Winning startups across the pet industry – from veterinary care to treats and e-commerce –…
COLCHESTER, Vt., Jan. 15, 2025 /PRNewswire/ -- Leading lab middleware company Data Innovations, LLC, has…
WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS)…